3.92
Ironwood Pharmaceuticals Inc Aktie (IRWD) Neueste Nachrichten
Ironwood Pharmaceuticals: A Contrarian Buy Opportunity (NASDAQ:IRWD) - Seeking Alpha
Ironwood Pharmaceuticals (IRWD) sets interim CFO fee and RSU grant - Stock Titan
Ironwood (IRWD) PFO Ronald Silver receives 25,000-share restricted stock grant - Stock Titan
Kyverna Therapeutics appoints Greg Martini as CFO - MSN
Is Ironwood Pharmaceuticals, Inc. (IRWD) a Comeback Pharma Stock After Major Earnings Improvement? - Insider Monkey
Ironwood Pharmaceuticals (IRWD) price target increased by 28.97% to 7.04 - MSN
Ironwood reiterates 2026 LINZESS guidance of $1.125B-$1.175B as STARS-2 initiation nears - MSN
Kyverna Therapeutics Appoints Greg Martini CFO Ahead of Potential Commercial Launch - citybiz
Top Small-Cap Stocks to Watch: Ironwood Pharmaceuticals (IRWD) L - GuruFocus
IRWD News | IRONWOOD PHARMACEUTICALS INC (NASDAQ:IRWD) - ChartMill
Ironwood Pharma drops after CFO transition - MSN
Ironwood Pharmaceuticals: Still A Profitable Opportunity (NASDAQ:IRWD) - Seeking Alpha
Armistice reports 15.03M Ironwood stake (NASDAQ: IRWD) in 13G/A - Stock Titan
Ironwood Pharmaceuticals, Inc.Class A Common Stock (NQ: IRWD - FinancialContent
Renaissance reports 4.90% stake in Ironwood (IRWD) - Stock Titan
Craig-Hallum Maintains Ironwood Pharmaceuticals(IRWD.US) With Buy Rating - Moomoo
Ironwood Pharma Announces CFO Resignation and Interim Successor - The Globe and Mail
Ironwood stock down despite Q1 earnings and revenue beat - MSN
Earnings call transcript: Ironwood’s Q1 2026 earnings beat forecasts, stock dips - Investing.com
Ironwood Pharmaceuticals: CFO Resignation Knocks SharesA Downgrade Is Due (NASDAQ:IRWD) - Seeking Alpha
Ironwood Pharmaceuticals (IRWD) Shares Drop 12% After CFO Resignation Announcement - GuruFocus
Ironwood Pharma stock drops after CFO exit (IRWD:NASDAQ) - Seeking Alpha
Ironwood Pharmaceuticals, Inc. Files Form 8-K with SEC: Company Details and Regulatory Disclosures - Minichart
Ironwood Pharmaceuticals IncGregory Martini resigns as CFO effective May 15, 2026SEC filing - marketscreener.com
[8-K] IRONWOOD PHARMACEUTICALS INC Reports Material Event - Stock Titan
TradingKey - TradingKey
Ironwood Pharmaceuticals stock (US46333X1081): Revenue surge and earnings beat signal turnaround - AD HOC NEWS
Ironwood Pharmaceuticals, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:IRWD) 2026-05-11 - Seeking Alpha
Results: Ironwood Pharmaceuticals, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - simplywall.st
Results: Ironwood Pharmaceuticals, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - 富途牛牛
Ironwood Pharmaceuticals (NASDAQ:IRWD) Downgraded by Wall Street Zen to "Hold" - MarketBeat
Ironwood Stock Down Despite Q1 Earnings and Revenue Beat - sharewise.com
Ironwood Pharmaceuticals Q1 Earnings Call Highlights - sharewise.com
Q1 2026 Ironwood Pharmaceuticals Inc Earnings Call Transcript - GuruFocus
Ironwood: Q1 Earnings Snapshot - theheraldreview.com
Ironwood (IRWD) turns loss to profit as LINZESS drives Q1 2026 revenue surge - Stock Titan
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):